UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Evaluation of copper-64-ATSM for non invasive imaging of tumour hypoxia by positron emission

Wood, KA; (2009) Evaluation of copper-64-ATSM for non invasive imaging of tumour hypoxia by positron emission. Doctoral thesis , UCL (University College London). Green open access

[img]
Preview
Text
WoodKA_thesis.Redacted.pdf

Download (24MB) | Preview

Abstract

MCu(II)-diacetyl-bis(A-methyl-thiosemicarbazone) (64Cu-ATSM) has been proposed as a positron emitting radiotracer to delineate tumour hypoxia using positron emission tomography (PET). In this study evaluation of this radiotracer was carried out in the P22 carcinosarcoma BD-9 rat tumour model. The distribution of 64Cu-ATSM with the immunohistochemical marker of hypoxia, pimonidazole, was compared using autoradiography and pimonidazole staining at early (1 hour) and late (20.5 hours) time-points after tracer injection however no correlation was found. The impact of tumour blood flow in determining tumour distribution of 64Cu-ATSM Gadolinium- enhanced MRI scanning was investigated. This showed a correlation between 64Cu- ATSM and blood flow up to twenty minutes after the administration of 64Cu-ATSM, an association beyond this time-point was not seen. A further study examined the effect of increased tumour hypoxia on uptake and retention of 64Cu-ATSM using the vascular disrupting agent combretastatin A4 phosphate (CA4P). No correlation between 64Cu-ATSM uptake and retention and hypoxia was seen in the tumours administered 64Cu-ATSM after CA4P administration, however a negative correlation between 64Cu-ATSM uptake and hypoxia was seen in the tumours receiving 64Cu-ATSM 10 minutes prior to CA4P administration. This strong negative association is likely to reflect the distribution of 64Cu-ATSM fixed at the time of administration of the vascular disrupting agent CA4P preventing its movement elsewhere in the tumour. In this tumour model 64Cu-ATSM distribution reflects tumour blood flow for twenty minutes after its administration. As such, fixation of the distribution of 64Cu-ATSM 10 minutes post-injection is likely to reflect tumour blood flow, explaining the negative association between 64Cu-ATSM and hypoxia observed in this part of the study. Evaluation of 64Cu-ATSM in the P22 tumour model has demonstrated that although it is tumour-avid it does not represent tumour hypoxia.

Type: Thesis (Doctoral)
Title: Evaluation of copper-64-ATSM for non invasive imaging of tumour hypoxia by positron emission
Identifier: PQ ETD:593362
Open access status: An open access version is available from UCL Discovery
Language: English
Additional information: Thesis digitised by ProQuest. Third party copyright material has been removed from the ethesis. Images identifying individuals have been redacted or partially redacted to protect their identity.
URI: http://discovery.ucl.ac.uk/id/eprint/1446036
Downloads since deposit
20Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item